Nalipsy

Sodium Valproate BP

Composition : Sodium Valproate BP 200 mg.

Indications : It is indicated for the treatment of all types of epilepsy, e.g. partial seizures, absence seizures, generalized tonic-clonic seizures, myoclonic seizures, atonic seizures, mixed seizures that include absence attack.

Dosage and Administration : Epilepsy: Adults: Initially 600mg daily in 2 divided doses, preferably after food, increased by 200mg at 3 days intervals to maximum 2.5gm per day in divided doses until control of seizure is achieved. Usual maintenance dose: 1- 2gm daily (20-30mg/kg daily). Children bodyweight up to 20kg: Initially 20mg/kg daily in divided doses, may be increased provided plasma concentration monitored (dose above 40mg/kg daily also monitor clinical chemistry and haematological parameters). Children under 12 years bodyweight over 20kg: Initially 400mg daily in divided doses increased according to response (usual range 20-30mg/kg daily), maximum 35mg/kg daily. Or, as directed by the registered physician.

Use in pregnancy and lactation : Sodium valproate crosses the placenta in humans; exposure to valproate in the first trimester causes neural tube defects such as anencephaly and spina bifida in newborn. Sodium valproate is excreted in human breast milk. It is not known what effect this would have on a breastfed infant. This drug should be used during pregnancy & lactation only if clearly needed.

Packing : Nalipsy Tablet: Each box contains 10x10's tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.